Exploring the acceptability of the available pneumococcal conjugate vaccines in Canadian health care professionals and immunization experts

To consider implementing any changes to the current program, most participants would require more evidence regarding PCV10 cross-protection and effectiveness against OM. Decreasing vaccine price was cited as a positive outcome of funding both vaccines.